These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 28867318)
1. Regression of Recurrent High-Grade Glioma with Temozolomide, Dexamethasone, and Levetiracetam: Case Report and Review of the Literature. Kumar A A; Abraham Koshy A World Neurosurg; 2017 Dec; 108():990.e11-990.e16. PubMed ID: 28867318 [TBL] [Abstract][Full Text] [Related]
2. Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy. Grosu AL; Weber WA; Franz M; Stärk S; Piert M; Thamm R; Gumprecht H; Schwaiger M; Molls M; Nieder C Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):511-9. PubMed ID: 16168843 [TBL] [Abstract][Full Text] [Related]
3. A phase I study of the combination of sorafenib with temozolomide and radiation therapy for the treatment of primary and recurrent high-grade gliomas. Den RB; Kamrava M; Sheng Z; Werner-Wasik M; Dougherty E; Marinucchi M; Lawrence YR; Hegarty S; Hyslop T; Andrews DW; Glass J; Friedman DP; Green MR; Camphausen K; Dicker AP Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):321-8. PubMed ID: 22687197 [TBL] [Abstract][Full Text] [Related]
4. Temozolomide chemotherapy of patients with recurrent anaplastic astrocytomas and glioblastomas. Sipos L; Vitanovics D; Afra D Ideggyogy Sz; 2004 Nov; 57(11-12):394-9. PubMed ID: 15662767 [TBL] [Abstract][Full Text] [Related]
5. [Favourable result for temozolomide in recurrent high-grade glioma]. Taal W; van der Rijt CD; Sillevis Smitt PA; Kros JM; van Heuvel I; Enting RH; van den Bent MJ Ned Tijdschr Geneeskd; 2005 Jun; 149(25):1393-9. PubMed ID: 15997692 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and toxicity of postoperative temozolomide radiochemotherapy in malignant glioma. Kocher M; Kunze S; Eich HT; Semrau R; Müller RP Strahlenther Onkol; 2005 Mar; 181(3):157-63. PubMed ID: 15756519 [TBL] [Abstract][Full Text] [Related]
7. Long-term outcome of oligodendrogliomas. Lebrun C; Fontaine D; Ramaioli A; Vandenbos F; Chanalet S; Lonjon M; Michiels JF; Bourg V; Paquis P; Chatel M; Frenay M; Neurology; 2004 May; 62(10):1783-7. PubMed ID: 15159478 [TBL] [Abstract][Full Text] [Related]
8. Regression of a glioblastoma multiforme: spontaneous versus a potential antineoplastic effect of dexamethasone and levetiracetam. Peddi P; Ajit NE; Burton GV; El-Osta H BMJ Case Rep; 2016 Dec; 2016():. PubMed ID: 28011886 [TBL] [Abstract][Full Text] [Related]
9. Phase I study of temozolomide and escalating doses of oral etoposide for adults with recurrent malignant glioma. Korones DN; Benita-Weiss M; Coyle TE; Mechtler L; Bushunow P; Evans B; Reardon DA; Quinn JA; Friedman H Cancer; 2003 Apr; 97(8):1963-8. PubMed ID: 12673724 [TBL] [Abstract][Full Text] [Related]
10. Temozolomide in the treatment of recurrent malignant glioma. Chang SM; Theodosopoulos P; Lamborn K; Malec M; Rabbitt J; Page M; Prados MD Cancer; 2004 Feb; 100(3):605-11. PubMed ID: 14745879 [TBL] [Abstract][Full Text] [Related]
11. Interobserver variability in the radiological assessment of response to chemotherapy in glioma. Vos MJ; Uitdehaag BM; Barkhof F; Heimans JJ; Baayen HC; Boogerd W; Castelijns JA; Elkhuizen PH; Postma TJ Neurology; 2003 Mar; 60(5):826-30. PubMed ID: 12629241 [TBL] [Abstract][Full Text] [Related]
12. Temozolomide and oral VP-16 for children and young adults with recurrent or treatment-induced malignant gliomas. Korones DN; Smith A; Foreman N; Bouffet E Pediatr Blood Cancer; 2006 Jul; 47(1):37-41. PubMed ID: 16047359 [TBL] [Abstract][Full Text] [Related]
13. Sunitinib Malate plus Lomustine for Patients with Temozolomide-refractory Recurrent Anaplastic or Low-grade Glioma. Duerinck J; Du Four S; Sander W; Van Binst AM; Everaert H; Michotte A; Hau P; Neyns B Anticancer Res; 2015 Oct; 35(10):5551-7. PubMed ID: 26408725 [TBL] [Abstract][Full Text] [Related]
14. Response of recurrent anaplastic ependymoma to a combination of tamoxifen and isotretinoin. Rojas-Marcos I; Calvet D; Janoray P; Delattre JY Neurology; 2003 Oct; 61(7):1019-20. PubMed ID: 14557591 [No Abstract] [Full Text] [Related]
15. Efficacy of temozolomide treatment in patients with high-grade glioma. Oshiro S; Tsugu H; Komatsu F; Ohmura T; Ohta M; Sakamoto S; Fukushima T; Inoue T Anticancer Res; 2009 Mar; 29(3):911-7. PubMed ID: 19414327 [TBL] [Abstract][Full Text] [Related]
17. Singapore Cancer Network (SCAN) Guidelines for Systemic Therapy of High-Grade Glioma. Singapore Cancer Network (SCAN) Neuro-Oncology Workgroup Ann Acad Med Singap; 2015 Oct; 44(10):463-73. PubMed ID: 26763064 [TBL] [Abstract][Full Text] [Related]
18. An algorithm for chemotherapy treatment of recurrent glioma patients after temozolomide failure in the general oncology setting. Kyritsis AP; Levin VA Cancer Chemother Pharmacol; 2011 May; 67(5):971-83. PubMed ID: 21442438 [TBL] [Abstract][Full Text] [Related]
19. Combined radiotherapy and temozolomide in patients with recurrent high grade glioma. Schönekaes K; Mücke R; Panke J; Rama B; Wagner W Tumori; 2002; 88(1):28-31. PubMed ID: 12004846 [TBL] [Abstract][Full Text] [Related]
20. [Pattern of care of high-grade gliomas]. Laigle-Donadey F; Sanson M Rev Prat; 2006 Oct; 56(16):1779-86. PubMed ID: 17315503 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]